Featured studies include clinical advances with a new combination therapy targeting angiogenesis in platinum-resistant ovarian cancer and a promising immunotherapy combination for kidney cancer, plus laboratory studies that focus on targeting ferroptosis in specific lung cancers, developing chimeric antigen receptor (CAR) T cell therapies for blastic plasmacytoid dendritic cell neoplasms, and characterizing racial and ethnic disparities in breast cancer early detection.
Laws designed to help women with increased risk for missed breast cancer diagnoses may help catch the disease earlier, according to Penn State College of Medicine researchers.
Now more than ever, we are reminded that health and wellness should always be a top priority. National Women’s Health Month and Mother’s Day, both celebrated in May, are important reminders that women can take control of their health by making feasible lifestyle choices and focusing on preventive care to lower the risk of certain cancers.
The physicians focused on how Black women dealt with getting screened and unique issues relevant to them. They revealed their findings recently in the Journal of Breast Imaging in “Breast Cancer Screening Recommendations: African American Women Are at a Disadvantage.”
Solis Mammography, the nation’s largest independent provider of breast health and diagnostic services, is expanding access to 3D mammography and diagnostic breast health procedures through a partnership with University of Chicago Medicine.
While researchers continue to make advances in breast cancer detection and treatment, one of the best ways to tackle the disease is through early detection and screening. Rutgers Cancer Institute expert shares more about risk factors, warning signs, and screening.
To mark National Cancer Prevention Month, The University of New Mexico Men’s and Women’s basketball teams hope to pack the house with pink in coming weeks in honor of breast cancer survivors and fighters.
In a new effort to improve early breast cancer detection and reduce false positive exams in women with dense breasts, the American College of Radiology, Breast Cancer Research Foundation and GE Healthcare are partnering to support the Contrast Enhanced Mammography Imaging Screening Trial (CMIST).